How this company measures up on the fundamentals that matter
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
https://www.cardinalhealth.com
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $195, 36% above fair value of $144. Passes all ethical screens. Ranks better than 52% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | HALL PATRICIA HEMINGWAY | Director | 381 | $79,183 | |
| 2026-02-27 | GREENE MICHELLE D | Chief Technology Officer | 2,746 | $627,387 | |
| 2026-02-18 | ALT AARON E. | Chief Financial Officer | 2,328 | $524,964 | |
| 2026-02-06 | HALL PATRICIA HEMINGWAY | Director | 4,000 | $918,880 | |
| 2026-01-15 | PITTEROFF VALERIE CHRISTINE | Officer | 3,982 | $849,201 | |
| 2025-11-05 | MUSSLEWHITE ROBERT W | Director | 1,067 | — | |
| 2025-11-05 | KENNY GREGORY B | Director | 1,702 | — | |
| 2025-11-05 | JOHRI AKHIL | Director | 1,067 | — | |
| 2025-11-05 | HALL PATRICIA HEMINGWAY | Director | 1,067 | — | |
| 2025-11-05 | KILLEFER NANCY | Director | 1,067 | — |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15